PROVIDER PROFILE · NPI 1407000227
Keisha Ashmeade
PRESCRIBING · PART D · 2024
Total Rx claims
327
Beneficiaries
—
Total drug cost
$465K
Distinct drugs
15
Brand share
58.1%
Top prescribed drugs
Atorvastatin Calcium51 claims
Bictegrav/Emtricit/Tenofov Ala42 claims
Elviteg/Cob/Emtri/Tenof Alafen33 claims
Dolutegravir Sodium/Lamivudine32 claims
Raltegravir Potassium22 claims
CROSS-REFERENCE